Novavax
Utility Patents
Last updated:
List of all Novavax patents 12 in total
| Status | Patent |
|---|---|
Grant | Utility: Vaccine compositions having improved stability and immunogenicity Filling date: 6 Sep 2025 Issue date: 21 Jun 2022 |
Grant | Utility: Multivalent influenza nanoparticle vaccines Filling date: 6 Sep 2025 Issue date: 22 Mar 2022 |
Grant | Utility: Coronavirus vaccine formulations Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Vaccine compositions having improved stability and immunogenicity Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Methods and compositions for inducing immune responses against Clostridium difficile Filling date: 6 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Modified RSV F proteins and methods of their use Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Coronavirus vaccine formulations Filling date: 6 Sep 2025 Issue date: 23 Mar 2021 |
Grant | Utility: Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods Filling date: 6 Sep 2025 Issue date: 25 Aug 2020 |
Grant | Utility: Functional influenza virus like particles (VLPs) Filling date: 6 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Functional influenza virus-like particles (VLPS) Filling date: 6 Sep 2025 Issue date: 4 Feb 2020 |
Grant | Utility: Highly efficient influenza matrix (M1) proteins Filling date: 6 Sep 2025 Issue date: 28 Jan 2020 |
Grant | Utility: Vaccine compositions having improved stability and immunogenicity Filling date: 6 Sep 2025 Issue date: 1 Oct 2019 |
Showing 1 to 12 of 12 patents.